Structural Formula (3f939480 7edb 406e 896a C2055d0b09ea 01)
Buspirone Hydrochloride Tablet
Product Images NDC 71335-2820
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71335-2820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (3f939480 7edb 406e 896a C2055d0b09ea 02)
This text provides guidance on how to divide 15 mg and 30 mg tablets according to your doctor's prescription. For the 15 mg tablet, it explains how to separate it into 10 mg (two-thirds of a tablet) and 5 mg (one-third of a tablet), among other options. Similarly, for the 30 mg tablet, it details how to divide it into 20 mg (two-thirds of a tablet) and 10 mg (one-third of a tablet), along with other alternatives. This information can be useful for accurately following dosage instructions.*
Figure (3f939480 7edb 406e 896a C2055d0b09ea 03)
Label (Lbl713352820)
This text contains information on a medication called Buspirone Hydrochloride tablets, each containing 7.5 mg of the active ingredient. The dosage instructions, storage conditions, and manufacturer details are also mentioned. It is important to refer to the package insert for complete prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
